Publications by authors named "Fiona Sherman"

Claim this Profile
D
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945.
Yueyang Wang, Yuan Hao, Michela Ranieri, Tigran M Abramyan, Lev Tsidilkovski, Fiona Sherman

NPJ Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models.
Dezhi Li, Ke Geng, Yuan Hao, Jiajia Gu, Saurav Kumar, Fiona Sherman

J Clin Invest· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer.
Xinyuan Tong, Ayushi S Patel, Eejung Kim, Hongjun Li, Yueqing Chen, Fiona Sherman

Cancer Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.
Atsushi Okato, Takanobu Utsumi, Michela Ranieri, Xingnan Zheng, Mi Zhou, Fiona Sherman

J Clin Invest· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
Suman Mukhopadhyay, Hsin-Yi Huang, Ziyan Lin, Michela Ranieri, Shuai Li, Fiona Sherman

Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC.
Hua Zhang, Christopher S Nabel, Dezhi Li, Ruth Í O'Connor, Caroline R Crosby, Fiona Sherman

J Thorac Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.
Yuanwang Pan, Han Han, Hai Hu, Hua Wang, Yueqiang Song, Fiona Sherman

Cancer Cell· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer.
Yuanwang Pan, Yuan Hao, Han Han, Ting Chen, Hailin Ding, Fiona Sherman

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis